Researchers identify strategy for overcoming resistance to RAS-targeted cancer drugs
Researchers at Roswell Park Comprehensive Cancer Center have identified a promising strategy for overcoming one of the biggest challenges facing KRAS-targeted cancer therapies: treatment resistance. Results of the preclinical study, led by Roswell Park faculty members Vishnu Kumarasamy, Ph.D., Agnieszka Witkiewicz, M.D., and Erik Knudsen, Ph.D., were published in Cancer Research.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
New strategy exploits a hidden genetic vulnerability in multiple cancers
United Kingdom
-
Extreme heat may raise suicide risk by disrupting sleep and emotional regulation, study finds
United Kingdom
-
Researchers identify strategy to make pediatric bone cancers more vulnerable to immunotherapy
United Kingdom
-
Simple conversational tool identifies dementia risk in developing countries
United Kingdom
-
Exploring sex differences in how the brain adapts to overeating
United Kingdom
-
Rapid genome sequencing helps guide care for about 50% of children with cancer
United Kingdom
-
After adult-onset hearing loss, an adaptation in the brain may improve vision
United Kingdom
-
Tracking loneliness, depression, and social behaviors in children from disaster-affected community
United Kingdom